← 返回

局部晚期宫颈癌 (LACC) 的体素内不相干运动 (IVIM) MR 定量:评估肿瘤侵袭性和新辅助化疗反应的初步研究

英文原题:Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy.

查看英文原题

Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy.

PubMed 2022/04/15(内容时间) J Pers Med

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

从 IVIM 模型中提取的 D 可能是一种有前景的工具,用于识别肿瘤侵袭性并预测治疗反应。

研究思路结论见上方概要

纳入20例经活检证实为宫颈癌、基线MRI分期为LACC并接受新辅助化疗的患者。治疗结束时,通过随访MRI评估肿瘤反应,采用修订版实体瘤疗效评价标准(RECIST;1.1版),若患者达到完全缓解或部分缓解则视为良好反应者(GR),若疾病稳定或进展则视为不良反应者/无反应者(PR/NR)。MRI方案包括常规扩散加权成像(DWI;b = 0和1000 s/mm²)以及使用八个b值(范围:0-1500 s/mm²)的IVIM采集。使用专用软件分析MR图像以获得定量参数:来自IVIM模型的扩散(D)、假扩散(D*)和灌注分数(fp);来自常规DWI的表观扩散系数(ADC)。对每例LACC评估组织学亚型、分级和TIL(肿瘤浸润淋巴细胞)(TILs)。

D 在 GR 患者中显示出显著更高的值(p = 0.001),在中等/高 TILs 中也显示出显著更高的值(p = 0.018)。Fp 在鳞状细胞肿瘤中显示出显著更高的值(p = 0.006)。

展开英文摘要原文

Twenty patients with biopsy-proven cervical cancer, staged as LACC on baseline MRI and addressed for neoadjuvant chemotherapy were enrolled. At treatment completion, tumor response was assessed with a follow-up MRI evaluated using the revised response evaluation criteria in solid tumors (RECIST; version 1.1), and patients were considered good responders (GR) if they had complete response or partial remission, and poor responders/non-responders (PR/NR) if they had stable or progressive disease. MRI protocol included conventional diffusion-weighted imaging (DWI; b = 0 and 1000 s/mm 2 ) and IVIM acquisition using eight b-values (range: 0-1500 s/mm 2 ). MR-images were analyzed using a dedicated software to obtain quantitative parameters: diffusion (D), pseudo-diffusion (D*), and perfusion fraction (fp) from the IVIM model; apparent diffusion coefficient (ADC) from conventional DWI. Histologic subtype, grading, and tumor-infiltrating lymphocytes (TILs) were assessed in each LACC.

D showed significantly higher values in GR patients ( p = 0.001) and in moderate/high TILs ( p = 0.018). Fp showed significantly higher values in squamous cell tumors ( p = 0.006).

D extracted from the IVIM model could represent a promising tool to identify tumor aggressiveness and predict response to therapy.

论文信息

作者
Dolciami M、Capuani S、Celli V、Maiuro A、Pernazza A、Palaia I、Di Donato V、Santangelo G
单位
Department of Radiological, Oncological and Pathological Sciences, Umberto I Hospital, Sapienza University of Rome, 00161 Rome, Italy.Italy
期刊
Journal of personalized medicine2022 Apr 15
原文标识
PubMed 35455755 · DOI 10.3390/jpm12040638